nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—Tiotropium—chronic obstructive pulmonary disease	0.712	1	CrCtD
Aclidinium—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.079	0.369	CbGbCtD
Aclidinium—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.0505	0.236	CbGbCtD
Aclidinium—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0439	0.205	CbGbCtD
Aclidinium—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0405	0.189	CbGbCtD
Aclidinium—Bladder neck obstruction—Tiotropium—chronic obstructive pulmonary disease	0.0161	0.233	CcSEcCtD
Aclidinium—Bronchospasm paradoxical—Tiotropium—chronic obstructive pulmonary disease	0.0053	0.0769	CcSEcCtD
Aclidinium—Bronchospasm paradoxical—Arformoterol—chronic obstructive pulmonary disease	0.00428	0.0621	CcSEcCtD
Aclidinium—Bronchospasm paradoxical—Formoterol—chronic obstructive pulmonary disease	0.00428	0.0621	CcSEcCtD
Aclidinium—Bronchospasm paradoxical—Salbutamol—chronic obstructive pulmonary disease	0.00404	0.0586	CcSEcCtD
Aclidinium—Cardio-respiratory arrest—Aminophylline—chronic obstructive pulmonary disease	0.00228	0.0331	CcSEcCtD
Aclidinium—Dysphonia—Tiotropium—chronic obstructive pulmonary disease	0.000935	0.0136	CcSEcCtD
Aclidinium—Dysphonia—Arformoterol—chronic obstructive pulmonary disease	0.000754	0.0109	CcSEcCtD
Aclidinium—Dysphonia—Formoterol—chronic obstructive pulmonary disease	0.000754	0.0109	CcSEcCtD
Aclidinium—Dysphonia—Salbutamol—chronic obstructive pulmonary disease	0.000712	0.0103	CcSEcCtD
Aclidinium—Infestation NOS—Roflumilast—chronic obstructive pulmonary disease	0.000684	0.00992	CcSEcCtD
Aclidinium—Infestation—Roflumilast—chronic obstructive pulmonary disease	0.000684	0.00992	CcSEcCtD
Aclidinium—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.000642	0.00931	CcSEcCtD
Aclidinium—BCHE—diaphragm—chronic obstructive pulmonary disease	0.000625	0.569	CbGeAlD
Aclidinium—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.000616	0.00893	CcSEcCtD
Aclidinium—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.000563	0.00817	CcSEcCtD
Aclidinium—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000553	0.00803	CcSEcCtD
Aclidinium—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.000531	0.0077	CcSEcCtD
Aclidinium—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.0071	CcSEcCtD
Aclidinium—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000433	0.00629	CcSEcCtD
Aclidinium—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000428	0.00621	CcSEcCtD
Aclidinium—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000404	0.00586	CcSEcCtD
Aclidinium—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000403	0.00584	CcSEcCtD
Aclidinium—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000403	0.00584	CcSEcCtD
Aclidinium—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000395	0.00572	CcSEcCtD
Aclidinium—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.000387	0.00562	CcSEcCtD
Aclidinium—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000381	0.00553	CcSEcCtD
Aclidinium—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00552	CcSEcCtD
Aclidinium—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00549	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000377	0.00546	CcSEcCtD
Aclidinium—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000361	0.00524	CcSEcCtD
Aclidinium—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00505	CcSEcCtD
Aclidinium—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.00034	0.00493	CcSEcCtD
Aclidinium—Infestation—Montelukast—chronic obstructive pulmonary disease	0.00034	0.00493	CcSEcCtD
Aclidinium—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000326	0.00473	CcSEcCtD
Aclidinium—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.00473	CcSEcCtD
Aclidinium—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000319	0.00463	CcSEcCtD
Aclidinium—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000317	0.0046	CcSEcCtD
Aclidinium—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00453	CcSEcCtD
Aclidinium—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00453	CcSEcCtD
Aclidinium—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.00447	CcSEcCtD
Aclidinium—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000308	0.00447	CcSEcCtD
Aclidinium—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.00446	CcSEcCtD
Aclidinium—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000306	0.00444	CcSEcCtD
Aclidinium—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000305	0.00443	CcSEcCtD
Aclidinium—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.00443	CcSEcCtD
Aclidinium—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000301	0.00437	CcSEcCtD
Aclidinium—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000299	0.00434	CcSEcCtD
Aclidinium—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000298	0.00433	CcSEcCtD
Aclidinium—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00428	CcSEcCtD
Aclidinium—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00426	CcSEcCtD
Aclidinium—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00422	CcSEcCtD
Aclidinium—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000289	0.00419	CcSEcCtD
Aclidinium—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.00419	CcSEcCtD
Aclidinium—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00414	CcSEcCtD
Aclidinium—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.00412	CcSEcCtD
Aclidinium—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00408	CcSEcCtD
Aclidinium—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00408	CcSEcCtD
Aclidinium—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.00407	CcSEcCtD
Aclidinium—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00028	0.00406	CcSEcCtD
Aclidinium—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000277	0.00402	CcSEcCtD
Aclidinium—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00399	CcSEcCtD
Aclidinium—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000273	0.00397	CcSEcCtD
Aclidinium—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000273	0.00395	CcSEcCtD
Aclidinium—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.0039	CcSEcCtD
Aclidinium—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00388	CcSEcCtD
Aclidinium—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00385	CcSEcCtD
Aclidinium—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.00354	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000237	0.00344	CcSEcCtD
Aclidinium—Cough—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00343	CcSEcCtD
Aclidinium—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00343	CcSEcCtD
Aclidinium—Cough—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00336	CcSEcCtD
Aclidinium—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00328	CcSEcCtD
Aclidinium—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00328	CcSEcCtD
Aclidinium—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00324	CcSEcCtD
Aclidinium—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00319	CcSEcCtD
Aclidinium—Infection—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00319	CcSEcCtD
Aclidinium—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00315	CcSEcCtD
Aclidinium—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00315	CcSEcCtD
Aclidinium—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00314	CcSEcCtD
Aclidinium—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00314	CcSEcCtD
Aclidinium—Infection—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00313	CcSEcCtD
Aclidinium—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00309	CcSEcCtD
Aclidinium—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00309	CcSEcCtD
Aclidinium—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00301	CcSEcCtD
Aclidinium—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00297	CcSEcCtD
Aclidinium—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00296	CcSEcCtD
Aclidinium—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00296	CcSEcCtD
Aclidinium—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000199	0.00289	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00277	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00277	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00272	CcSEcCtD
Aclidinium—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000185	0.00268	CcSEcCtD
Aclidinium—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000182	0.00264	CcSEcCtD
Aclidinium—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00264	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00262	CcSEcCtD
Aclidinium—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000177	0.00257	CcSEcCtD
Aclidinium—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000174	0.00253	CcSEcCtD
Aclidinium—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000172	0.00249	CcSEcCtD
Aclidinium—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000151	0.0022	CcSEcCtD
Aclidinium—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.0022	CcSEcCtD
Aclidinium—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00215	CcSEcCtD
Aclidinium—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00208	CcSEcCtD
Aclidinium—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00204	CcSEcCtD
Aclidinium—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00204	CcSEcCtD
Aclidinium—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00201	CcSEcCtD
Aclidinium—Headache—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00201	CcSEcCtD
Aclidinium—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00201	CcSEcCtD
Aclidinium—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000138	0.002	CcSEcCtD
Aclidinium—Headache—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00197	CcSEcCtD
Aclidinium—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00193	CcSEcCtD
Aclidinium—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.0019	CcSEcCtD
Aclidinium—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.0017	CcSEcCtD
Aclidinium—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00166	CcSEcCtD
Aclidinium—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00146	CcSEcCtD
Aclidinium—Infection—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.00126	CcSEcCtD
Aclidinium—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	8.55e-05	0.00124	CcSEcCtD
Aclidinium—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.00123	CcSEcCtD
Aclidinium—Headache—Prednisolone—chronic obstructive pulmonary disease	7.51e-05	0.00109	CcSEcCtD
Aclidinium—CHRM1—trachea—chronic obstructive pulmonary disease	7.22e-05	0.0658	CbGeAlD
Aclidinium—BCHE—respiratory system—chronic obstructive pulmonary disease	7.14e-05	0.065	CbGeAlD
Aclidinium—CHRM3—smooth muscle tissue—chronic obstructive pulmonary disease	7.04e-05	0.0641	CbGeAlD
Aclidinium—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.000865	CcSEcCtD
Aclidinium—BCHE—bronchus—chronic obstructive pulmonary disease	5.88e-05	0.0535	CbGeAlD
Aclidinium—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	5.75e-05	0.0523	CbGeAlD
Aclidinium—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000804	CcSEcCtD
Aclidinium—Headache—Prednisone—chronic obstructive pulmonary disease	5.46e-05	0.000792	CcSEcCtD
Aclidinium—BCHE—trachea—chronic obstructive pulmonary disease	5.28e-05	0.048	CbGeAlD
Aclidinium—CHRM1—lung—chronic obstructive pulmonary disease	5.19e-05	0.0473	CbGeAlD
Aclidinium—BCHE—lung—chronic obstructive pulmonary disease	3.79e-05	0.0345	CbGeAlD
Aclidinium—CHRM3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	9.86e-06	0.00249	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	9.82e-06	0.00248	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	9.77e-06	0.00247	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.69e-06	0.00245	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.62e-06	0.00243	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	9.6e-06	0.00243	CbGpPWpGaD
Aclidinium—CHRM4—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	9.43e-06	0.00238	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.29e-06	0.00235	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.22e-06	0.00233	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.19e-06	0.00232	CbGpPWpGaD
Aclidinium—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.08e-06	0.00229	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.05e-06	0.00229	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	9.04e-06	0.00228	CbGpPWpGaD
Aclidinium—CHRM5—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	9.03e-06	0.00228	CbGpPWpGaD
Aclidinium—CHRM4—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	8.96e-06	0.00226	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	8.96e-06	0.00226	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	8.89e-06	0.00225	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.89e-06	0.00225	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	8.86e-06	0.00224	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.8e-06	0.00222	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.79e-06	0.00222	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	8.78e-06	0.00222	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.51e-06	0.00215	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.47e-06	0.00214	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.44e-06	0.00213	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.41e-06	0.00212	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.4e-06	0.00212	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.36e-06	0.00211	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	8.28e-06	0.00209	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	8.09e-06	0.00204	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	8.08e-06	0.00204	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	7.94e-06	0.00201	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.78e-06	0.00196	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.75e-06	0.00196	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.69e-06	0.00194	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.68e-06	0.00194	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.67e-06	0.00194	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.59e-06	0.00192	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.58e-06	0.00191	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.55e-06	0.00191	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.48e-06	0.00189	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	7.26e-06	0.00183	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.15e-06	0.0018	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.13e-06	0.0018	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	6.95e-06	0.00176	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.83e-06	0.00172	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.83e-06	0.00172	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.8e-06	0.00172	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.77e-06	0.00171	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.75e-06	0.0017	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.74e-06	0.0017	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.74e-06	0.0017	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	6.74e-06	0.0017	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	6.73e-06	0.0017	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.7e-06	0.00169	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.68e-06	0.00169	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.46e-06	0.00163	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.45e-06	0.00163	CbGpPWpGaD
Aclidinium—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	6.36e-06	0.00161	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.35e-06	0.0016	CbGpPWpGaD
Aclidinium—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	6.34e-06	0.0016	CbGpPWpGaD
Aclidinium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	6.28e-06	0.00159	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.2e-06	0.00157	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.18e-06	0.00156	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.12e-06	0.00155	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.08e-06	0.00154	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.99e-06	0.00151	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.98e-06	0.00151	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	5.97e-06	0.00151	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.92e-06	0.0015	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.92e-06	0.00149	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.9e-06	0.00149	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.85e-06	0.00148	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.77e-06	0.00146	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.76e-06	0.00146	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.68e-06	0.00143	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.52e-06	0.00139	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.43e-06	0.00137	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.43e-06	0.00137	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.43e-06	0.00137	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.2e-06	0.00131	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.2e-06	0.00131	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	5.19e-06	0.00131	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	5.18e-06	0.00131	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.15e-06	0.0013	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	5.02e-06	0.00127	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.96e-06	0.00125	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.94e-06	0.00125	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.94e-06	0.00125	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	4.88e-06	0.00123	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.81e-06	0.00121	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.79e-06	0.00121	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.75e-06	0.0012	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.74e-06	0.0012	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.74e-06	0.0012	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.73e-06	0.00119	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.65e-06	0.00117	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.55e-06	0.00115	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.54e-06	0.00115	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.53e-06	0.00114	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.51e-06	0.00114	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.48e-06	0.00113	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	4.45e-06	0.00113	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.32e-06	0.00109	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.28e-06	0.00108	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.27e-06	0.00108	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.23e-06	0.00107	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	4.2e-06	0.00106	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.1e-06	0.00104	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.97e-06	0.001	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.89e-06	0.000982	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.88e-06	0.000979	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.85e-06	0.000972	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.84e-06	0.00097	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.83e-06	0.000966	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.81e-06	0.000963	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.8e-06	0.00096	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.8e-06	0.000959	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.78e-06	0.000954	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	3.75e-06	0.000948	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.69e-06	0.000932	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.66e-06	0.000925	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.66e-06	0.000924	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.65e-06	0.000922	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.65e-06	0.000921	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.65e-06	0.000921	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.63e-06	0.000918	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.61e-06	0.000913	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.61e-06	0.000912	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.54e-06	0.000893	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.47e-06	0.000878	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.46e-06	0.000875	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.43e-06	0.000866	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	3.43e-06	0.000865	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.42e-06	0.000865	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.41e-06	0.00086	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.38e-06	0.000853	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.35e-06	0.000846	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	3.34e-06	0.000843	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.34e-06	0.000843	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.3e-06	0.000835	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.26e-06	0.000824	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.16e-06	0.000797	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.15e-06	0.000795	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.07e-06	0.000775	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.04e-06	0.000769	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.04e-06	0.000768	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.03e-06	0.000765	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3e-06	0.000758	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.98e-06	0.000753	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.94e-06	0.000742	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.92e-06	0.000736	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.79e-06	0.000703	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.77e-06	0.000699	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.68e-06	0.000676	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.67e-06	0.000674	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.67e-06	0.000674	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.66e-06	0.000673	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.65e-06	0.000669	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.64e-06	0.000668	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.63e-06	0.000665	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.6e-06	0.000656	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.55e-06	0.000644	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.49e-06	0.000629	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.48e-06	0.000627	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.48e-06	0.000625	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.46e-06	0.000621	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.42e-06	0.000611	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.37e-06	0.000599	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.3e-06	0.00058	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.29e-06	0.000579	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.29e-06	0.000578	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.27e-06	0.000573	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.07e-06	0.000522	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.06e-06	0.000521	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.05e-06	0.000518	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.05e-06	0.000517	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.04e-06	0.000516	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.04e-06	0.000514	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	2.03e-06	0.000512	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.03e-06	0.000512	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.95e-06	0.000492	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.94e-06	0.000491	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	1.94e-06	0.00049	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.88e-06	0.000474	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.87e-06	0.000473	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.87e-06	0.000471	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.86e-06	0.00047	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.86e-06	0.00047	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.85e-06	0.000469	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.85e-06	0.000468	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.84e-06	0.000465	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.8e-06	0.000454	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.79e-06	0.000452	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.78e-06	0.000449	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.77e-06	0.000448	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.67e-06	0.000422	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.66e-06	0.00042	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.65e-06	0.000416	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.65e-06	0.000416	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.58e-06	0.000398	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.56e-06	0.000395	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	1.56e-06	0.000394	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.5e-06	0.000378	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.49e-06	0.000377	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.49e-06	0.000376	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.43e-06	0.00036	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.37e-06	0.000347	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.37e-06	0.000346	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.36e-06	0.000342	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.34e-06	0.000338	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.31e-06	0.000331	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.31e-06	0.00033	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.29e-06	0.000327	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.28e-06	0.000323	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.25e-06	0.000316	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.25e-06	0.000315	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.23e-06	0.000312	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.23e-06	0.00031	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.2e-06	0.000304	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.17e-06	0.000297	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.15e-06	0.000291	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.11e-06	0.00028	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.11e-06	0.000279	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.1e-06	0.000277	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.05e-06	0.000266	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.05e-06	0.000266	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.04e-06	0.000263	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.01e-06	0.000255	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1e-06	0.000253	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1e-06	0.000253	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.91e-07	0.00025	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.67e-07	0.000244	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.24e-07	0.000233	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.01e-07	0.000228	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.98e-07	0.000227	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.89e-07	0.000225	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.85e-07	0.000224	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.27e-07	0.000209	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.24e-07	0.000208	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.16e-07	0.000206	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.11e-07	0.000205	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.08e-07	0.000204	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8e-07	0.000202	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.81e-07	0.000172	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.79e-07	0.000171	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.72e-07	0.00017	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.23e-07	0.000157	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.21e-07	0.000157	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.15e-07	0.000155	CbGpPWpGaD
